miR-218 inhibited tumor angiogenesis by targeting ROBO1 in gastric cancer.

Aberrant expression of miRNAs is involved in several carcinogenic processes, including tumor growth, metastasis and angiogenesis. The aim of this study was to determine the role of miR-218 in gastric cancer angiogenesis. In situ hybridization was performed on a set of tissue microarray samples to assess the difference in miR-218 expression in vessels between tumor tissues and normal gastric mucosa. In vitro, ectopic expression of miR-218 disturbed the tubular structure and inhibited the migration of endothelial cells. Motility and tube formation were rescued when miR-218 was downregulated. Moreover, miR-218 suppressed endothelial cell sprouting in a fibrin bead sprouting assay. Subsequently, we identified ROBO1 as a target of miR-218 in endothelial cells and determined it was responsible for the effect of miR-218 on tumor angiogenesis. In vivo, local injection of mature miR-218 in xenografted tumors disrupted the vessel plexus and thus inhibited tumor growth. Taken together, our study demonstrated an anti-angiogenic role of miR-218 in gastric cancer and indicated that delivery of miR-218 may be a potential therapeutic strategy to inhibit tumor angiogenesis.

[1]  P. Lai,et al.  Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin. , 2013, Gastroenterology.

[2]  D. Fan,et al.  POU2F2-oriented network promotes human gastric cancer metastasis , 2015, Gut.

[3]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[4]  Bei Sun,et al.  microRNA-218 Inhibits Oxygen-induced Retinal Neovascularization via Reducing the Expression of Roundabout 1 , 2016, Chinese medical journal.

[5]  D. Cheresh,et al.  Tumor angiogenesis: molecular pathways and therapeutic targets , 2011, Nature Medicine.

[6]  Li Wang,et al.  miR‐342‐5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling , 2016, Journal of the American Heart Association.

[7]  H. Augustin,et al.  Mechanisms of Vessel Pruning and Regression. , 2015, Developmental cell.

[8]  R. Hill,et al.  The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer , 2014, Oncotarget.

[9]  S. Anand,et al.  MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis , 2010, Nature Medicine.

[10]  Haifeng Jin,et al.  Potential role of vascular targeted therapy to combat against tumor , 2009, Expert opinion on drug delivery.

[11]  Weiying Zhou,et al.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. , 2014, Cancer cell.

[12]  C. Goodman,et al.  Biochemical Purification of a Mammalian Slit Protein as a Positive Regulator of Sensory Axon Elongation and Branching , 1999, Cell.

[13]  D. Fan,et al.  MiR-218 Inhibits Invasion and Metastasis of Gastric Cancer by Targeting the Robo1 Receptor , 2010, PLoS genetics.

[14]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[15]  J. Folkman,et al.  Clinical translation of angiogenesis inhibitors , 2002, Nature Reviews Cancer.

[16]  A. Chédotal,et al.  Slit2 signaling through Robo1 and Robo2 is required for retinal neovascularization , 2015, Nature Medicine.

[17]  M. N. Nakatsu,et al.  An optimized three-dimensional in vitro model for the analysis of angiogenesis. , 2008, Methods in enzymology.

[18]  Li Lin,et al.  Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. , 2011, Cancer cell.

[19]  E. Gomulia,et al.  The diagnostic and prognostic value of SALL4 in hepatoblastoma , 2016, Histopathology.

[20]  Weilan Ye,et al.  The Complexity of Translating Anti-angiogenesis Therapy from Basic Science to the Clinic. , 2016, Developmental cell.

[21]  Alain Chédotal,et al.  Novel roles for Slits and netrins: axon guidance cues as anticancer targets? , 2011, Nature Reviews Cancer.

[22]  C. Goodman,et al.  Slit Proteins Bind Robo Receptors and Have an Evolutionarily Conserved Role in Repulsive Axon Guidance , 1999, Cell.

[23]  Xinmin Liu,et al.  Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer , 2015, Angiogenesis.

[24]  R. Davuluri,et al.  miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma , 2013, Proceedings of the National Academy of Sciences.

[25]  Joshua D. Wythe,et al.  A Slit/miR-218/Robo regulatory loop is required during heart tube formation in zebrafish , 2011, Development.

[26]  Naotoshi Sugimoto,et al.  Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. , 2014, The Lancet. Oncology.

[27]  Xuejing Zhang,et al.  Prostaglandin F 2 a upregulates Slit/Robo expression in mouse corpus luteum during luteolysis , 2013 .

[28]  M. Herlyn,et al.  Slit-Robo: neuronal guides signal in tumor angiogenesis. , 2003, Cancer cell.

[29]  Gordon C Jayson,et al.  Antiangiogenic therapy in oncology: current status and future directions , 2016, The Lancet.

[30]  Eugene Berezikov,et al.  Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma , 2014, Oncotarget.

[31]  E. Olson,et al.  MicroRNA-218 Regulates Vascular Patterning by Modulation of Slit-Robo Signaling , 2010, Circulation research.

[32]  Marc Tessier-Lavigne,et al.  Diversity and Specificity of Actions of Slit2 Proteolytic Fragments in Axon Guidance , 2001, The Journal of Neuroscience.

[33]  X. Yang,et al.  MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1 , 2015, Tumor Biology.